[1] |
SONG Hai-jing, YANG Wei-zhi, ZHANG Zhuo-mei, OU Lun, Chen Fang, Wang Qing-qing, DONG Li-hou, LIU Xiu-wen.
Clinical Phase I Pharmacokinetics of rhproUK
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(6): 672-676.
|
[2] |
CAI Yong-ming, CHEN Zheng-min, SUN Chao-yuan, LIU Chang-xiao.
Bioanalytical method and pharmacokinetics of Bacillus subtilis fibrinolytic enzyme in rhesus monkeys
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(1): 27-31.
|
[3] |
SHEN Dan-dan, BIAN Zhi-ping, HE Guo-ping, GU Chun-rong, XU Jin-dan, YANG Di, ZHANG Ji-nan.
Establishment of a sandwich ELISA for quantitative measurement of human supersensitivity C-reactive protein and primary clinical application study
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(1): 84-89.
|
[4] |
WANG Xing, WANG De-guo, KE Yong-sheng, TANG Zheng-guo, YANG Yu-wen, WANG An-cai.
Effects of antidigoxin antiserum on expression of NOSs in ischemiareperfusion myocardium of rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(7): 753-757.
|
[5] |
DENG Li-juan, LIN Fei, LIU Li-hua.
Study on immunogenicity of recombinant glucagons-like peptide-1(7-36)
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(12): 1388-1391.
|
[6] |
WANG Jing, GUAN Yong-biao.
In vivo analytical methods for polypeptide drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(11): 1309-1314.
|
[7] |
XIA Dong-ya, GUO Tao, JIANG Ling.
Monitoring whole blood concentration of tacrolimus in 1190 samples from liver transplant recipients by ELISA
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(8): 933-936.
|
[8] |
ZHENG Zhuan-jie, FANG Yi, WANG Rui.
Measurement of recombinant human glucagon-like peptide-1 (7-36) concentration by ELISA kit methods
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(4): 444-447.
|
[9] |
YU Hong-e, YU Qing-sheng, LIU Xin-yan, ZHU Liu, LOU Xiao-hua, TENG Mai-kun.
China cobra venom active factor (CCVAF) inhibits VEGF and bFGF in lung cancer cell line H1299
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(9): 970-973.
|
[10] |
LIU Wei, ZHOU Hong, DING Guo-fu, LU Yong-ling, WANG Liang-xi, LUO Ping.
Protective effects of CpG oligonucleotide on mice with bacterial sepsis and its mechanism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(3): 314-317.
|
[11] |
LIN Qiu-xiong, SHAN Zhi-xin, YU Xi-yong, Yang Ming, LIN Shu-guang, Hui-yao LAN.
Effects of different lipid on MIF mRNA and protein expression in cultural macrophage
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(3): 329-332.
|
[12] |
FU Hong-yan, Xu Bo, WANG Hong-jun, GONG Ze-hui.
Comparison of drugs effect on MHV-A59 virus by established DBT cell model
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(11): 1253-1256.
|
[13] |
KE Yong-Sheng, YANG Hao, YANG Ting, CHENG Guang-Hua, WANG You-Xia.
Effect of anti-digoxin antiserum on endogenous digitalis-like factor and membrane ATPase activity in hypoxic injury myocardium1
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2000, 5(1): 10-12.
|